Follow the Caplin Point Laboratories Limited share price and the full insider trade history of the company, a listed issuer based in India. Shares trade on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Caplin Point Laboratories Limited has published 38 reports. Market capitalisation: €191.3bn. The latest transaction was reported on 23 March 2023 (Purchase). Among the most active insiders: Arulsudar Natrajan. All data is accessible without an account.
38
Insider Decl.
n/a
Thresholds
€6m
32 ops.
Buy Volume
€149,936
6 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Caplin Point Laboratories Limited Strong Buy (bullish), based on 2 analysts. Average price target: ₹2,505.00.
10Σ signal
Buys €6m€149,936 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 6,954 of 28,856 companies
64.5
score / 100
Value
41
Quality
88
FCF yld1.4%
Earn yld3.4%
EV/EBITDA21.8x
ROE20%
Gross mgn60%
Net mgn29%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
8,333 shares@ ₹2.00100.0% of flowEquity SharesSEBI:6e68ca78914a300dec36065b80d0a4fc72d065b9
25 of 38 declarations
About Caplin Point Laboratories Limited
Caplin Point Laboratories Limited is a pharmaceutical company specializing in the manufacture of generic drugs and injectable formulations. It is listed on the XBOM market.